American Journal of Kidney Diseases
Volume 44, Issue 1 , Pages 77-83 , July 2004

The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF

  • My Svensson, MD

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    • Corresponding Author InformationAddress reprint requests to My Svensson, MD, Department of Nephrology, Aalborg Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark
    • ,
  • Jeppe Hagstrup Christensen, MD, DMSci

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    • Department of Preventive Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Jakob Sølling, MD, DMSci

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    • Department of Preventive Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Erik Berg Schmidt, MD, DMSci

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    • Department of Preventive Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

Received 8 January 2004 ,Accepted 11 March 2004.

References 

  1. Levin A, Foley R. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis. 2000;36(suppl 3):S24–S30
  2. Levey A, Beto J, Coronado B, et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease (What do we know? What do we need to learn? Where do we go from here?). Am J Kidney Dis. 1998;32:853–906
  3. Garg AX, Clark WF, Haynes B, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality (Results from the NHANES 1). Kidney Int. 2002;61:1486–1494
  4. Longenecker JC, Coresh J, Powe NR, et al.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population (The CHOICE study). J Am Soc Nephrol. 2002;13:1918–1927
  5. Koenig W. Update on C-reactive protein as a risk marker in cardiovascular disease. Kidney Int Suppl. 2003;84:S58–S61
  6. National Kidney Foundation . K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41(suppl 3):S8–S58
  7. Deighan C, Caslake M, McConnell M, Boulton-Jones JM, Packard C. Atherogenic lipoprotein phenotype in end-stage renal failure (Origin and extent of small dense low-density lipoprotein formation). Am J Kidney Dis. 2000;35:852–862
  8. Rajman I, Harper L, McPake D, Kendall M, Wheeler D. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant. 1998;13:2281–2287
  9. Sarnak MJ, Levey AS, Schoolwerth AC, et al.  Kidney disease as a risk factor for development of cardiovascular disease. AHA scientific statement. Circulation. 2003;108:2154–2169
  10. Burr ML, Feihly AM, Gilbert JF, et al.  Effects of changes in fat, fish and fibre intakes on death and myocardial infarction; Diet and Reinfarction Trial (DART). Lancet. 1989;30:757–761
  11. GISSI Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction; Results of the GISSI Prevenzione trial. Lancet. 1999;354:447–455
  12. Kris-Etherton P, Harris W, Appel L  Nutrition Committee . Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation. 2002;106:2747–2757
  13. Daviglus M, Stamler J, Orencia A, et al.  Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046–1053
  14. Siscovick D, Raghunathan TE, King I, et al.  Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000;71:208–212
  15. Albert C, Campos H, Stampfer M, et al.  Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:113–118
  16. Christensen JH. n-3 Fatty acids and the risk of sudden cardiac death (Emphasis on heart variability). Dan Med Bull. 2003;50:347–367
  17. Harris WS. n-3 Fatty acids and serum lipoproteins (Human studies). Am J Clin Nutr. 1997;65(suppl 5):S1645–S1654
  18. Schmidt EB. n-3 Fatty acids and the risk of coronary heart disease. Dan Med Bull. 1997;44:1–22
  19. Appel L, Miller E, Seidler A, Whelton P. Does supplementation of diet with fish oil reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993;153:1429–1438
  20. Morris M, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523–533
  21. Geleijnse J, Giltay E, Grobbee D, et al.  Blood pressure response to fish oil supplementation (Metaregression analysis of randomised trials). J Hypertens. 2002;20:1493–1499
  22. Christensen JH, Skou HA, Fog L, et al.  Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation. 2001;103:651–657
  23. Beynen AC, Katan MB. Rapid sampling and long-time storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition. Am J Clin Nutr. 1985;42:317–322
  24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917
  25. Christoffersen SW, Glass RL. Preparation of milk fat methyl esters by alcoholysis in an essentially non-alcoholic solution. J Dairy Sci. 1969;52:1289–1290
  26. Austin M, Hokanson J, Edwards K. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B
  27. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Circulation. 2002;106:3143–3421
  28. Sarnak MJ, Coronado BE, Greene T, et al.  Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002;57:327–335
  29. Uhlig K, Levey A, Sarnak M. Traditional risk factors in individuals with chronic kidney disease. Semin Dial. 2003;16:118–127
  30. Azar R, Dequiedt F, Awada J, Dequiedt P, Tacquet A. Effects of fish oil rich in polyunsaturated fatty acids on hyperlipemia of hemodialysis patients. Kidney Int Suppl. 1989;27:S239–S242
  31. Rolf N, Tenschert W, Lison AE. Results of long-term administration of omega-3 fatty acids in hemodialysis patients with dyslipoproteinaemia. Nephrol Dial Transplant. 1990;5:797–801
  32. Khajedi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr. 2000;10:191–195
  33. Nordøy A. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease. Minerva Med. 2002;93:357–363
  34. Lowrie EG, Lew NL. Death risk in hemodialysis patients (The predictive rate of commonly measured variables and an evaluation of death rate differences between facilities). Am J Kidney Dis. 1990;15:458–482
  35. Iseki K, Yamazato M, Tozawa M, Takashita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61:1887–1893
  36. Baigent C, Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int Suppl. 2003;84:S207–S210
  37. Holdaas H, Fellstrøm B, Jardine A, et al.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients (A multicentre, randomised, placebo-controlled trial). Lancet. 2003;361:2024–2031
  38. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein(a) as a risk factor for ischemic heart disease (Metaanalysis of prospective studies). Clin Chem. 1998;44:2301–2306
  39. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Circulation. 2000;102:1082–1085
  40. Zimermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658
  41. Lungerhausen Y, Abbey M, Nestel P, Howe P. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 1994;12:1041–1045
  42. Singer P, Melzer S, Goschel M, Augustin S. Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension. 1990;16:682–691
  43. Russo C, Olivieri O, Girelli D, et al.  Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension. J Hypertens. 1995;13:1823–1826
  44. Bao DQ, Mori TA, Burke V, Puddey IB, Bellin LJ. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension. 1998;32:710–717
  45. Donadio J. n-3 Fatty acids and their role in nephrologic practice. Curr Opin Nephrol. 2001;10:639–642
  46. De Caterina R, Endres S, Kristensen SD, Schmidt EB. n-3 Fatty acids and renal diseases. Am J Kidney Dis. 1994;24:397–415
  47. Kutner NG, Clow PW, Zhang R, Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 2002;39:1018–1024

PII: S0272-6386(04)00507-4

doi: 10.1053/j.ajkd.2004.03.024

American Journal of Kidney Diseases
Volume 44, Issue 1 , Pages 77-83 , July 2004

Article Tools